Epstein Secrets

ort on Form 10-Q for the quarterly period ended September 30. 2015. to co a Ce3 which are incorporated herein by reference. ca os co a Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these a= >. securities or passed upon the accuracy or adequacy of this prospectus

estment decision. 21 EFTA00690342 U.S. Cellular United States Cellular Corporation % Senior Notes due PROSPECTUS SUPPLEMENT November , 2015 Joint Book-Running Managers BofA Merrill Lynch Morgan Stanley RBC Capital Markets UBS Investment Bank Wells Fargo Securities Lead Manager Citigroup Co-Managers BNY Mell

offering price. less the underwriting discount. within 30 days from the date of this prospectus supplement solely to cover over-allotments. None of the Securities and Exchange Commission, any state securities commission, the Registrar of Companies in Bermuda, the Bermuda Monetary Authority or any other regulatory body has approved or

orm only, through the facilities of The Depository Trust Company. against payment on or about June , 2016. See "Underwriting." BofA Merrill Lynch Joint Book-Running Managers Morgan Stanley UBS Investment Bank The date of this prospectus supplement is _tune , 2016. EFTA00618204 TABLE OF CONTENTS Prospectus Suppleme

Shares involves risks. See "Risk Factors" beginning on page S-2 of this prospectus supplement and the risks discussed in the documents we file with the U.S. Securities and Exchange Commission. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined i

the Depositary Shares subject to various conditions. The underwriters expect to deliver the Depositary Shares to purchasers on or about May , 2016. Joint Book-Running Managers BofA Merrill Lynch Morgan Stanley UBS Investment Bank Wells Fargo Securities May . 2016 EFTA00595846 You should rely only on the information co